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A B S T R A C T
Good’s syndrome (GS) is an immunodeﬁciency characterized by thymoma, hypogammaglobulinemia,
and impaired T-cell function. The clinical manifestations of GS include recurrent or chronic infections
from common or opportunistic pathogens. Encephalitis is a rare event, with only anecdotal reports of
cytomegalovirus infection. Herein we report the case of a 79-year-old woman with GS who developed
subacute motor deﬁcits and cognitive changes. Magnetic resonance imaging (MRI) of the brain disclosed
white- and gray-matter lesions, mostly in the right frontal and parietal areas. Polyoma virus JC, the agent
of progressive multifocal encephalopathy (PML), was identiﬁed in cerebrospinal ﬂuid samples and brain
biopsy specimens. After diagnosis, the disease had a rapid fatal course. The present case represents the
ﬁrst reported association between GS and PML.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Good’s syndrome (GS) is an adult-onset primary immunodeﬁ-
ciency combining hypogammaglobulinemia and thymoma, which
presents inabout10%ofpatientspriororafter thymomaresection.1,2
Additional immunologic defects in GS may include altered T-cell
functionwith lowCD4cells, andan invertedratioofCD4 toCD8cells.
The humoral and cellular immunodeﬁciency in GS is responsible for
recurrent respiratory, gastrointestinal, and urinary infections from
commonandopportunisticbacterial and fungalpathogens;2,3 40%of
patients develop opportunistic viral infections, and three patients
with cytomegalovirus encephalitis have been reported.4,5 PML, an
infection caused by JC virus (JCV), usually occurs in patients infected
with HIV, or in patients on treatment with immunosuppressive or
immunomodulatory drugs. Herein we describe the ﬁrst unusual
association between GS and PML.
2. Case report
A 79-year-old woman was admitted to our neurology unit
because of short-lasting episodes of paresthesias and progres-* Corresponding author. Tel.: +39 045 8122690; fax: +39 045 8122100.
E-mail address: neurogio@tiscali.it (G. Squintani).
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doi:10.1016/j.ijid.2009.06.005sive weakness of the left hand. Five months earlier the patient
experienced difﬁculties in motor planning with her left hand
and attention deﬁcits. Eight years before admission, the patient
underwent resection of an epithelial thymoma, and thereafter,
she developed hypogammaglobulinemia, which was treated
with intravenous immunoglobulin at a dose of 400 mg/kg/day
for 3 days on a bimonthly basis. On admission, her lymphocyte
count was 2.14  109 cells/l, and lymphocyte subgroups were
normal (CD4/CD8 T-cell ratio 1.5; CD4 648/mm3; CD8 425/
mm3); B cells were absent. The total IgG level was 619 mg/dl
(normal range 700–1600), the IgA level was less than 25 mg/dl
(normal range 70–400), and IgM level was less than 18 mg/dl
(normal range 40–250). Magnetic resonance imaging (MRI) of
the brain showed bilateral ﬂair and T2-weighted hyperinten-
sities in the frontal and parietal cortices abutting the white
matter, more on the right. No gadolinium enhancement was
detected. Neuropsychological evaluation disclosed visual atten-
tion and working memory impairment, in addition to mild
ideational apraxia. After a brief rehabilitation course, the patient
partially recovered her arm function, and she was discharged.
During the following days, she developed progressive weakness
on the left side and presented visual hallucinations. On
readmission, one month later, a severe left spastic hemiparesis
was noted, in addition to visual agnosia for objects and faces,
dyscalculia, and severe ideomotor apraxia.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. (A, B) Axial T2-weighted brain magnetic resonance images (MRI) showing hyperintensities in frontal and parietal subcortical areas and thalamic nuclei, bilaterally.
(C) Coronal ﬂair sequences showing hyperintensities at the level of cortical–subcortical junction and basal ganglia.
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weighted hyperintensities in the frontal, parietal, and temporal
lobes, in the thalami and in the right basal ganglia (Figure 1); there
was no enhancement after the administration of gadolinium. An
electroencephalogram (EEG) revealed diffuse bilateral theta–delta
activity with sporadic sharp-wave prevalent in the right parietal
region. Lumbar puncture yielded clear cerebrospinal ﬂuid (CSF)
with normal protein, glucose and cell count. PCR analysis for JCV in
the cerebrospinal ﬂuid was positive.
A brain biopsy specimen from the frontal lobe disclosed
demyelinating lesions, bizarre astrocytes, and viral inclusions in
enlarged oligodendrocyte nuclei, ultrastructurally consistent with
polyomavirus particles (Figure 2). The diagnosis of JCV infectionwas later conﬁrmed by quantitative real-time PCR of the CSF (9258
pairs/ml). Cidofovir (5 mg/kg/week), in association with probene-
cid, was administered without beneﬁt. The patient developed
cortical blindness, spastic tetraparesis, and died of Pseudomonas
aeruginosa pneumonia ﬁve months after disease onset. Postmor-
tem examination conﬁrmed the diagnosis of PML and showed
multiple cortico-subcortical lesions.
3. Discussion
First described by Good in 1954,1 GS is currently classiﬁed as a
distinct primary immunodeﬁciency syndrome. Immunologic
defects in GS are not limited to hypogammaglobulinemia and
Figure 2. (A) Brain biopsy specimen showing bizarre astrocytes and abnormal oligodendrocyte nuclei (hematoxylin and eosin stain; scale bar: 50 mm). (B) Oligodendrocyte
nucleus containing particles of JC virus (electronmicrograph; scale bar: 0.5 mm). (C) Immunocytochemistry of the frontal cortexwithmonoclonal anti-CD68 antibody (Dako),
recognizing cells frommacrophage lineage, depicts activated microglial cell at the gray/white matter junction (scale bar: 100mm), and (D) in the cerebellar cortex and white
matter (scale bar: 100mm).
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deﬁcient CD4 lymphocytes and decreased or inverted CD4/CD8
ratio.3 This explains the increased incidence of opportunistic
infections in patients with GS, as compared to individuals with
other forms of hypogammaglobulinemia. Moreover, altered T-cell
function in GS is also supported by the occurrence of cutaneous
anergy to test antigens, delayed rejection of skin allografts, and
diminished inducible cytokine production.3,6
The most frequent clinical manifestations of GS include
recurrent sino-pulmonary, gastrointestinal, and urinary tract
bacterial infections, either from common or opportunistic patho-
gens, cytomegalovirus (CMV) disease, oral or esophageal candi-
diasis.2 Encephalitis is very uncommon in GS, and only three
patientswith CMV encephalitis have been reported.4,5 On the other
hand, the association between thymoma and PML is very unusual,
with only two cases described.7,8 This index case represents the
ﬁrst reported association between GS and PML. PML usually occurs
in patients with hematological malignancies or HIV infection, in
addition to immunosuppressed individuals in treatment with
methotrexate, cyclophosphamide, azathioprine, natalizumab and
rituximab.
Of note, PML has also been reported in patients with defective
cell-mediated immunity, and, occasionally, in subjects with
impaired B-cell function, such as common variable immunodeﬁ-
ciency, congenital hypogammaglobulinemia, and X-linked agam-
maglobulinemia.9,10 In the present case, the association between
GS and PML can tentatively be explained by a coexisting T-cellfunctional defect, in spite of a normal lymphocyte count and
lymphocyte subgroup representation.
Common manifestations of PML include subacute hemipar-
esis, gait or limb ataxia, hemianopsia, and cognitive impairment,
as an effect of multiple lesions of the subcortical hemispheric
white matter.11 Less frequently, involvement of cortical gray
matter or deep gray nuclei, such as basal ganglia and thalamus,
have been reported, always in conjunction with white matter
disease.11,12 Intriguingly, in our patient gray-matter involve-
ment occurred at the presentation, a ﬁnding which precluded an
early diagnosis. The early and prevailing impairment of cerebral
cortical regions was also supported by repeat neuropsycholo-
gical studies showing cognitive dysfunctions, including
working memory impairment, ideomotor apraxia and agno-
sia.13,14 In conclusion, the present report suggests that PML
should be considered in the setting of patients with GS and CNS
involvement, even in cases presenting with cognitive dysfunc-
tion.
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